Falls, Functioning, and Disability Among Women With Persistent Symptoms of Chemotherapy-Induced Peripheral Neuropathy

Overview of attention for article published in Journal of Clinical Oncology, June 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 4 news outlets
blogs: 1 blog
twitter: 128 X users

patent: 2 patents
facebook: 7 Facebook pages
guideline: 1 clinical guideline source

Readers on

mendeley: 280 Mendeley

So far, Altmetric has seen 8 public wall posts from 7 users.

abcd - After Breast Cancer Diagnosis, 23 Dec 2019

We need more research on this - mine is worsening on perjeta

Kate Smedley, 29 Jun 2017

An important read. According to the article 'After an average of 6 years after treatment, 47% of women still reported symptoms…

abcd - After Breast Cancer Diagnosis, 29 Jun 2017

Disturbing data on late effects of chemotherapy. We need to do better. Falls and disability among women with persistent…

Wellness For Cancer, 23 Jun 2017

Chemotherapy-induced peripheral neuropathy (CIPN) may persist after treatment ends and may lead to functional decline and falls.

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity, including 4 additional Facebook posts.